Indeed, the available evidence indicates that in TNBC, PD‐L1 expression is more frequent (up to 60%) than in other breast cancers, and that PD‐L1 tumor expression is positively associated with stromal TILs.19 The gene discussed is CD274; the disease is breast carcinoma.